Abstract
Metabolic engineering of heterologous pathways has allowed the production of therapeutically important compounds in microbial systems. Here, we report the engineering of a monoterpenoid biosynthetic pathway into Escherichia coli. Five genes encoding sequential enzymes for perillyl alcohol biosynthesis from the precursors isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) were engineered into E. coli. Expression of these genes allowed the production of the intermediate limonene, but the downstream monoterpenoid, perillyl alcohol, was not detected. A new compound was detected but could not be identified based on the data obtained. Only 1.6 μg/ml of the compound was being produced from the engineered E. coli strain, but, when these cultures were fed limonene as a substrate, the production was nearly 250 μg/ml. This unknown compound inhibited the cell proliferation of MCF-7 and MDA-MB-231 breast cancer cells in 48-h treatment experiments. This compound may have potential benefits in breast cancer treatment. This is the first report showing the production of a monoterpenoid in engineered E. coli and its antiproliferative effects in breast cancer cells.
Similar content being viewed by others
References
Martin, V. J., Pitera, D. J., Withers, S. T., Newman, J. D., & Keasling, J. D. (2003). Nature Biotechnology, 21(7), 796–802.
Paddon, C. J., & Keasling, J. D. (2014). Nature Reviews Microbiology, 12(7446), 355–367.
Ajikumar, P. K., Xiao, W. H., Tyo, K. E., Wang, Y., Simeon, F., Leonard, E., Mucha, O., Phon, T. H., Pfeifer, B., & Stephanopoulos, G. (2010). Science, 330(6000), 70–74.
Huang, Q., Roessner, C. A., Croteau, R., & Scott, A. I. (2001). Bio-organic Medicinal Chemistry, 9(9), 2237–2242.
Azzoli, C. G., Miller, V. A., Ng, K. K., Krug, L. M., Spriggs, D. R., Tong, W. P., Riedel, E. R., & Kris, M. G. (2003). Cancer Chemotherapy and Pharmacology, 51(6), 493–498.
Bailey, H. H., Attia, S., Love, R. R., Fass, T., Chappell, R., Tutsch, K., Harris, L., Jumonville, A., Hansen, R., Shapiro, G. R., & Stewart, J. A. (2008). Cancer Chemotherapy and Pharmacology, 62(1), 149–157.
Crowell, P. L., Siar Ayoubi, A., & Burke, Y. D. (1996). Advances in Experimental Medicine and Biology, 401, 131–136.
Meadows, S. M., Mulkerin, D., Berlin, J., Bailey, H., Kolesar, J., Warren, D., & Thomas, J. P. (2002). International Journal of Gastrointestinal Cancer, 32(2), 125–128.
Liu, G., Oettel, K., Bailey, H., Ummersen, L. V., Tutsch, K., Staab, M. J., Horvath, D., Alberti, D., Arzoomanian, R., Rezazadeh, H., McGovern, J., Robinson, E., DeMets, D., & Wilding, G. (2003). Investigational New Drugs, 21(3), 367–372.
Belanger, J. T. (1998). Alternative Medicine Review, 3(6), 448–457.
da Fonseca, C. O., Linden, R., Futuro, D., Gattass, C. R., & Quirico-Santos, T. (2008). Archivum Immunologiae et Therapiae Experimentalis, 56(4), 267–276.
Holstein, S. A., & Hohl, R. J. (2003). Journal of Lipid Research, 44(6), 1209–1215.
Chastain, D.E., Mody, N., Majetich, G. (1999), U. S. Patent, 5,994,598.
Kolomeyer, G.G., Ferone, D. A. (2010), U. S. Patent, 7,851,660 B1.
van Beilen, J. B., Holtackers, R., Luscher, D., Bauer, U., Witholt, B., & Duetz, W. A. (2005). Applied and Environmental Microbiology, 71(4), 1737–1744.
Anthony, J. R., Anthony, L. C., Nowroozi, F., Kwon, G., Newman, J. D., & Keasling, J. D. (2009). Metabolic Engineering, 11(1), 13–19.
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M., Wanner, B. L., & Mori, H. (2006). Molecular Systems Biology, 2, 2006.0008.
Ohnuma, S., Narita, K., Nakazawa, T., Ishida, C., Takeuchi, Y., Ohto, C., & Nishino, T. (1996). Journal of Biological Chemistry, 271(48), 30748–30754.
Reiling, K. K., Yoshikuni, Y., Martin, V. J., Newman, J., Bohlmann, J., & Keasling, J. D. (2004). Biotechnology and Bioengineering, 87(2), 200–212.
Zheng, L., Baumann, U., & Reymond, J. L. (2004). Nucleic Acids Research, 32(14), e115.
Colby, S. M., Alonso, W. R., Katahira, E. J., McGarvey, D. J., & Croteau, R. (1993). Journal of Biological Chemistry, 268(31), 23016–23024.
Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K., & Pease, L. R. (1989). Gene, 77(1), 61–68.
Amann, E., Ochs, B., & Abel, K. J. (1988). Gene, 69(2), 301–315.
Risticevic, S., Lord, H., Gorecki, T., Arthur, C. L., & Pawliszyn, J. (2010). Nature Protocols, 5(1), 122–139.
Lucero, M., Estell, R., Tellez, M., & Fredrickson, E. (2009). Phytochemical Analysis, 20(5), 378–384.
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990). Journal of the National Cancer Institute, 82(13), 1107–1112.
Vichai, V., & Kirtikara, K. (2006). Nature Protocols, 1(3), 1112–1116.
Bardon, S., Picard, K., & Martel, P. (1998). Nutrition and Cancer, 32(1), 1–7.
Takashi, Y., Danbara, N., Tsujita-Kyutoku, M., Kiyozuka, Y., Senzaki, H., Shikata, N., Kanzaki, H., & Tsubura, A. (2004). Breast Cancer Research and Treatment, 84(3), 251–260.
Duetz, W. A., Bouwmeester, H., van Beilen, J. B., & Witholt, B. (2003). Applied Microbiology and Biotechnology, 61(4), 269–277.
Duetz, W. A., Fjallman, A. H., Ren, S., Jourdat, C., & Witholt, B. (2001). Applied and Environmental Microbiology, 67(6), 2829–2832.
Lupien, S., Karp, F., Wildung, M., & Croteau, R. (1999). Archives of Biochemistry and Biophysics, 368(1), 181–192.
de Visser, S. P., Ogliaro, F., Sharma, P. K., & Shaik, S. (2002). Journal of the American Chemical Society, 124(39), 11809–11826.
Kille, S., Zilly, F. E., Acevedo, J. P., & Reetz, M. T. (2011). Nature Chemistry, 3(9), 738–743.
Acknowledgments
We acknowledge and thank the Department of Biological Sciences and the College of Graduate Studies, University of the Sciences, for the support of this project. We thank Dr. Catherine Moore and Dr. Natalia Coleman for generously providing the MDA-MB-231 cells and MCF-7 cells, respectively. We also thank Mr. Carl Walasek for his assistance with the statistical analyses.
Conflict of Interest
The authors declare no competing interests or conflicts of interest.
Author’s Contribution
SG, MGM, JRA, and JRP designed experiments, interpreted results, and participated in preparation of the manuscript; the experiments were conducted primarily by SG. FS participated in the design and interpretation of the GC-MS experiments. VAM and FS participated in revision of the manuscript. All authors agree with the findings and interpretations contained in the manuscript and agree to the submission to Applied Biochemistry and Biotechnology.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, S., Marko, M.G., Miller, V.A. et al. Novel Production of Terpenoids in Escherichia coli and Activities Against Breast Cancer Cell Lines. Appl Biochem Biotechnol 175, 2319–2331 (2015). https://doi.org/10.1007/s12010-014-1382-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-014-1382-4